Mr. David Moloney:

I have given two significant examples relating to the pricing of pharmaceutical drugs and the funding of the fair deal scheme. There are other examples. We have looked at various aspects of primary care and at care for the elderly. Much work has been done. The work by the IGEES economists and policy analysts in Government Departments has brought much greater clarity to what is being spent and what it is spent on, which greatly facilitates value-for-money assessments and how money is allocated within the health service. As the Deputy knows, there are considerable limitations in the information available about financial management in the HSE.